GPhA’s Drug Shortage Initiative Clears FTC Hurdle; Still Working With FDA

Five manufacturers have agreed to give IMS Health production and supply information about drugs in short supply; GPhA and IMS are working with FDA to finalize the details of the accelerated recovery initiative.